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Composite Reference Interval for Thyroid-Stimulating
Hormone and Free Thyroxine, Comparison with Common
Cutoff Values, and Reconsideration of Subclinical
Thyroid Disease
H. Alec Ross,1,2* Martin den Heijer,2 Ad R.M.M. Hermus,2 and Fred C.G.J. Sweep1
BACKGROUND: Examination of the 2-dimensional prob-
ability distribution of thyroid-stimulating hormone
(TSH) and free thyroxine (FT4) shows that the widths
of the TSH and FT4 reference intervals derived from
this bivariate distribution are mutually interdepen-
dent, an aspect commonly ignored when interpreting
thyroid testing results with separate reference intervals
for TSH and FT4. We desired to establish and critically
evaluate a composite reference interval for TSH and
FT4 to allow bivariate classification of biochemical thy-
roid conditions.
METHODS: FT4 and TSH results of 871 healthy individ-
uals [361 women and 510 men, 18–40 years old, with-
out history of thyroid-related disease or medication,
negative for anti–thyroid peroxidase (anti-TPO) anti-
body] were transformed to standard normal variables
by logarithmic transformation with correction for
skewness and subsequent normalization. We estab-
lished a 95% reference interval of the distance of
each FT4/TSH pair of values to the center of the
2-dimensional probability distribution.
RESULTS: The bivariate 95% reference interval is en-
closed by a circular profile with radius 2.45 SD. By con-
trast, conventional reference intervals comprise a
square with the boundaries of1.96 and1.96 SD for
both FT4 and TSH that enclose only 90% of all data.
Compared with the1.96 SD square, the bivariate ref-
erence interval classified 4% fewer of 3651 healthy in-
dividuals older than 40 years as subclinically hyperthy-
roid and 14% fewer of 712 anti-TPO–positive healthy
individuals as subclinically hypothyroid.
CONCLUSIONS: Conventional application of separate
cutoff values for FT4 and TSH leads to overestimation
of the incidence of subclinical thyroid disease. Ap-
plication of a composite overall reference interval is
recommended.
© 2009 American Association for Clinical Chemistry
Subclinical thyroid disease is defined as the combina-
tion of normal free thyroxine (FT4)
3 with either sub-
normal or increased thyroid-stimulating hormone
(TSH). It is common practice to apply the cutoff values
corresponding to the 95% reference intervals (either
parametrically or nonparametrically established) for
FT4 and TSH established in a healthy reference popu-
lation to decide how a particular FT4/TSH combina-
tion should be biochemically classified (1–3). In a TSH
vs FT4 diagram, this corresponds to division of the area
into 9 rectangular sections. In such a graphical presen-
tation (e.g., Fig. 1A), it is obvious that these limits do
not follow uniform probability densities. Moreover, a
95% reference interval obviously should enclose 95%
of the reference population, but the central section in
which all FT4 and TSH values fall within their corre-
sponding 1.96 SD limits encloses only 95% of 95%,
i.e., 90.25% of all data points. The remaining 9.75% is
distributed as follows: 0.25% for the combinations low/
low, high/low, low/high, and high/high FT4 and TSH
and 9.5% for the combinations normal/low, normal/
high, low/normal, and high/normal. Thus, 4.75% of
the reference populationwould be classified as subclin-
ically hyper- or hypothyroid.
Herein we propose a method to obtain a bivariate
95% reference interval for transformed and normal-
ized FT4 and TSH values. The reference interval is
based on combining these values in a function express-
ing the distance from the center of the 2-dimensional
distribution. We assume a uniform probability density
and set the cutoff limit so that about 5% of the refer-
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ence population will exceed this bivariate reference
limit. Because the reference population must be suit-
able to identify cases of subclinical thyroid conditions,
no signs of thyroid autonomy or failure should be con-
spicuous. Within a population harboring some degree
of thyroid autonomy, a negative correlation between
FT4 andTSH is expected due to negative feedback; con-
versely, in a group of individuals in which pituitary
failure occurs, a positive correlation is anticipated.
Therefore, if neither organ displays autonomy or fails
by itself, no correlation should be observed between
TSH and FT4. Basal TSH and FT4 concentrations de-
pend on the partially genetically determined pituitary-
thyroid set point (4 ) that appears to result in entirely
random combinations of FT4 and TSH values among
individuals. When this is the case, a bivariate reference
limit is easy to calculate.
To investigate the effect of this approach on the
definition of subclinical hyper- and hypothyroidism,
we estimated the frequencies of these conditions by
composite, bivariate, and conventional univariate ap-
proaches in a euthyroid older (compared to the refer-
ence group) age group without anti-TPO antibodies,
and in an anti-TPO–positive group.
Study Participants andMethods
The individuals included in this study originated from
the Nijmegen Biomedical study (5 ). Serum TSH was
measured by immunoluminometric assay in an Archi-
tect random access assay system (Abbott Diagnostics).
The functional detection limit (i.e., the concentration
at which the interassay CV is 20%) was 0.007mU/L. At
higher concentrations, interassay CVs were as follows:
3.3% at 0.250 mU/L, 3.6% at 1.72 mU/L, and 3.0% at
9.86 mU/L. Serum FT4 was estimated by a lumines-
cence enzyme immunoassay in a Vitros ECI random
access assay system (Ortho Clinical Diagnostics). This
assay uses a labeled anti-T4 antibody in a medium that
is essentially free of other extraneous T4-binding pro-
teins. Serum samples may be diluted up to 8 times
without significant effect on measurement results. In-
terassay CVs were as follows: 3.8% at 10.1 pmol/L,
4.5% at 15.8 pmol/L, and 4.6% at 28.7 pmol/L.
The total population consisted of 6434 individuals
age 18 years and older. After exclusion of all those with
self-reported thyroid disease and/or thyroid surgery,
those on thyromimetics and thyrostatics and on other
medication known to affect thyroid function or thy-
roid function parameters, pregnant women and
women on oral contraceptives, a group of 5235 healthy
individuals remained. Individuals with increased anti-
TPO antibodies (n  712) (aTPO group) were ex-
cluded, and of the remaining 4523, TSH and FT4
concentrations were logarithmically transformed in-
cluding a correction for skewness. Based on the mean
and SD of the transformed values, 14 outliers were
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Fig. 1. TSH and FT4 values as measured in the refer-
ence group.
(A), Untransformed values for data points, with reference
limits obtained by reversal of the transformation and nor-
malization, with conventional 1.96 SD limits (dotted lines)
and composite limits (solid lines). Sections outside the
curved reference zone correspond to thyroid conditions
outlined in the text. (B), Normalized, transformed TSH and
FT4 values for the reference group which formed the basis
of the composite reference limits.
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eliminated (see Appendix for transformation and out-
lier algorithms). In addition, 16 individuals with TSH
below the functional sensitivity limit of 0.007 mIU/L
were removed. Because we had observed a tendency
toward lower TSH and higher FT4 concentrations
with age (5 ), the reference group was restricted to
people 40 years old and younger (n  871). The dis-
tribution of transformed FT4 and TSH values in this
reference group was not found to differ from a normal
gaussian distribution. From these data, we made a
2-dimensional diagram of transformed TSH plotted
against transformed FT4. A reference limit was repre-
sented by a circular profile centered at (0,0), which
encloses a specified fraction of all data points. The re-
maining 3622 individuals were supplemented with re-
sults for the previously removed 13 of 14 outliers and
for 16 values with TSH below the functional detection
limit, all 40 years old, to form the older anti-TPO
negative (40, aTPO–) group (n 3651).
The squared normalized distance,D2, of each data
point to the center of the distribution for this reference
population equals the sum of the squared normalized
TSH and FT4 values and is given by the following
formula:
D2  log(TSH 0.303  0.243	/0.171]2
 log(FT4  11.2  1.39	/0.0324]
2. (1)
With the assumption that TSH and FT4 are uncorre-
lated, D2 is mathematically identical to the Mahalono-
bis distancemeasure traditionally used formultivariate
reference regions (6 ) and follows a 2 distributionwith
2 degrees of freedom so that P0.95 is at 5.99. For the
distanceD, the critical value is
5.99 or 2.45. The con-
stants 0.303 and 11.2 are corrections for skewness,
0.243 and 1.39 are the means of the transformed TSH
and FT4 values, and 0.171 and 0.0324 are the corre-
sponding SDs (see Appendix). Because all outliers ex-
cept one were 40 years old, outlier removal had no
effect on the parameters of the reference group.
The area outside the composite reference interval
may be subdivided into 8 sections (Fig. 1, A and B), i.e.,
the number of combinations of low, normal, and high
TSHandFT4with the combination normal/normal ex-
cluded. The 4 corner sections I, III, VI, and VIII repre-
sent the zones in which both TSH and FT4 exceed the
same absolute limit of 1.73 (2.45/
2) SD (or conven-
tionally, 1.96 SD). Section I represents overt hypo-
thyroidism with high TSH and low FT4, whereas sec-
tion VIII represents overt hyperthyroidism with high
FT4 and low TSH. Sections II and VII represent sub-
clinical hypo- and hyperthyroidism, respectively.
Using the z-test for population proportions, we
compared observed frequencies in the sections statisti-
cally to each other and expected values (7 ); P values
0.05 were considered significant. For P values0.25,
the predicate “not different” was assigned. Distribu-
tions were tested for normality by Kolmogorov–
Smirnov test (SPSS v. 16; SPSS Inc.).
Results
The distribution of transformed FT4 and TSH values in
the reference group was not found by Kolmogorov–
Smirnov testing to differ from a normal gaussian dis-
tribution. The separate 95% univariate reference inter-
vals obtained after reversal of the transformation were
0.51–3.48mIU/L for TSH and 9.8–16.9 pmol/L for FT4
(Fig. 1A). The circumference of the bivariate 95% ref-
erence region is given by Eq. 1, with the value 5.99
assigned toD2 (distanceD 2.45). For each FT4 value,
a pair of TSH values was obtained, representing the
TSH reference interval corresponding to that particu-
lar FT4 value. Thus, for an FT4 value of 13.1 pmol/L,
the lower and upper limits for TSH are 0.36 and
4.28mU/L, respectively. Conversely, if TSH is 1.45, the
range for FT4 is 9.0–18.0 pmol/L. Furthermore, if FT4
is 9 pmol/L, the reference interval for TSH would be
restricted to a single value of 1.45 mU/L.
When using the separate univariate reference in-
tervals for TSH and FT4, 10.8% (n 94) of data points
in the reference group fall outside the area in which
both criteria are met; by contrast, with the bivariate
composite approach, 5.2% (n  45) fall outside the
constructed combined reference region. Both numbers
fall close to the expected values of 9.75% and 5% (z-test
for population proportions). The same holds after fur-
ther subdivision into subclinical hypo- and hyperthy-
roidism (see Table 1): separate limits give 2.4% and
2.8% (expected 2.4% for both), and the bivariate com-
posite limit yields 1.2% and 0.8% (expected 1.1% for
both).
Fig. 2, A and B, shows the data from the group of
healthy older (40 years) individuals and healthy in-
dividuals with positive anti-TPO superimposed on the
reference grid.
Table 1 presents the observed frequencies of sub-
clinical hypo- and hyperthyroidism as assessed by the
composite and conventional methods. In many in-
stances, the differences between observed frequencies
were significantly greater than expected from inclusion
of a larger percentage of normal values (2.4% vs 1.1%)
alone. This observation was particularly apparent in
the frequency of subclinical hypothyroidism in the
anti-TPO positive group. The estimate of subclinical
hypothyroidism according to the conventional ap-
proach was almost 24%, whereas the composite ap-
proach indicated only 10%. In the elderly anti-TPO–
negative group, the observed frequency of subclinical
hypothyroidism was slightly higher than in the refer-
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ence group if the composite limits were used (1.5% vs
1.2%), but the difference was somewhat more pro-
nounced (3.3% vs 2.4%) when applying separate lim-
its. For subclinical hyperthyroidism, the composite ap-
proach gave frequencies for the elderly anti-TPO–
negative and anti-TPO–positive groups that were
higher than expected (3.4% and 2.8% vs 0.8%) on the
basis of the reference group, but not significantly dif-
ferent from each other. For the conventional method,
frequencies for the elderly anti-TPO–negative and
anti-TPO–positive groups were 7.3% and 5.1%, re-
spectively, vs 2.8%, of which the former is significantly
higher than the latter, whereas both are higher than in
the composite approach.
Discussion
Plots of TSH vs FT4 values from larger data sets show
that the shape of the density distribution of points is
egg-like (Fig. 1A) rather than rectangular.Whereas FT4
approximates a normal distribution, the distribution
of TSH is skewed, but approximates a normal distri-
bution after log transformation. Fine-tuning of the
transformation by correcting for residual skewness, ap-
plying log transformation for FT4 as well with subse-
quent normalization, results in a circular-shaped
2-dimensional diagram for healthy individuals without
any thyroid medication or sign of disease. This is a re-
flection that, if the negative feedback system is at equi-
librium, TSH and FT4 combine randomly among indi-
viduals. A negative correlation will be observed if
there is a tendency of thyroid autonomywithin the data
set, in the form of either thyroid hyperactivity or fail-
ure. Conversely, a trend toward pituitary autonomy
would lead to a positive correlation. If TSH and FT4 do
correlate, the density distribution will tend toward an
elliptic shape with Y X and YX as main axes. A
trivariate [TSH, FT4 index, free triiodothyronine (FT3)
index] probability density distribution was presented
by Kagedal et al. (8 ) for 3885 women 39–60 years of
age. In this group, negative correlations were observed
between logTSH and both FT4 and FT3 indices and a
positive correlation between FT4 and FT3 indices. This
resulted in an ellipsoidal frequency distribution and
reference limit.We also observed a negative correlation
between FT4 and logTSH for individuals40 years old,
which was the reason to exclude those from the refer-
ence group since our aim was to obtain a reference
group that is suitable for detecting subclinical thyroid
disease. Although the univariate probability density
distributions of FT4 and TSH are mutually indepen-
dent, the bivariate density distribution depends on
both FT4 and TSH, and therefore the reference limits
derived from the bivariate distribution for each param-
eter are mutually dependent. So the derived reference
limits for FT4 are further apart if TSH values tend to-
ward their average, than with TSH values toward the
extremes, and vice versa.
Classification of thyroid conditions on the basis of
a logTSH/FT4 diagram has been shown before (2 ). Al-
though the authors indicated in their graph that the
normal reference region was elliptical (and would be
circular after normalization) rather than rectangular,
this aspect was not further explored.
The squared distance of each data point to the cen-
ter of the distribution equals the sum of squared nor-
malized TSH and FT4 values. As a consequence of nor-
malization, TSH and FT4 each have a mean of 0 with
variance 1. Thus, each squared transformed and nor-
malized TSH and FT4 value is an estimate of this vari-
ance. Therefore, the sum of squared TSH and FT4 will
be 2 distributed with 2 degrees of freedom. The 95%
reference interval corresponds to a 2 value of 5.99, so
it encloses a circle with a radius of 2.45, which is the
square root of 5.99. Indeed, 94.8% of all data from the
reference group fall within this region; in contrast,
89.2% fall within the separately applied limits, mean-
ing that 5% of healthy individuals would be inappro-
Table 1. Observed and expected incidence rates in subclinical hyper- and hypothyroid ranges.
Composite Conventional
n
Subclinical
hypothyroid
Subclinical
hyperthyroid
Subclinical
hypothyroid
Subclinical
hyperthyroid
Expected incidence 0.0108 0.0108 0.0238 0.0238
Observed incidence
Reference 0.0115 0.00804 0.0241 0.0276 871
40, aTPO 0.0153a,b 0.0337a 0.0331a,b 0.0731a,b 3651
aTPO 0.101a,b 0.0281a 0.237a,b 0.0506a,b 712
a Significant difference (z-test for population proportions) with reference and expected.
b Significant difference between aTPO and 40, aTPO.
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priately classified as abnormal with the latter approach.
Conversely, with the composite approach, the number
of healthy individuals not requiring further investiga-
tion increases by 5%.
Subdivision of the area outside the reference inter-
val (see Fig. 1B) into sections corresponding to various
thyroid conditions is intuitive when using conven-
tional separate 95% limits at 1.96 SD. With the cir-
cular reference area it is somewhat less obvious. The
dividing lines must intersect at1.73 SD, by which the
corner sections will correspond to regions where not
only TSH and FT4 combined fall outside the reference
interval, but also separately exceed the same limit. This
limit is defined by the 4 points on the circle where the
absolute values of normalized TSH and FT4 are equal.
This is at 2.45/
2 1.73 SD.
For the reference population, the difference be-
tween conventional and bivariate composite classifica-
tions is almost exclusively located in the sections cor-
responding to the 4 possible combinations normal/
abnormal, 2 of which represent subclinical hyper- and
hypothyroidism.
Plotting the data from the healthy anti-TPO–neg-
ative participants older than 40 in the grid (Fig. 2, A and
B), it appears that the data are shifted downward and to
the right with respect to the reference group. This is a
corollary of observationswemade earlier (5 ). Interpre-
tation of this shift depends on whether the composite
reference limits or conventional reference limits are
used. Table 1 shows that there was a slight but signifi-
cant increase in frequency of subclinical hypothyroid-
ism compared to the reference group, but the differ-
ence tended to bemore pronouncedwith conventional
classification. This was also true when considering the
data from the anti-TPO–positive participants (Fig. 2B
and Table 1). The composite approach shows clearly
higher incidence of subclinical hypothyroidism with
respect to both the older anti-TPO negative and refer-
ence groups, but no difference with the former for sub-
clinical hyperthyroidism. Thus, the composite ap-
proach does not indicate a relation between anti-TPO
status and the incidence of subclinical hyperthyroid-
ism, whereas the conventional approach does. The
higher incidence of subclinical hyperthyroidism com-
pared to the younger reference group suggests an age
effect instead.
Because the purpose of this report is presentation
of the composite reference interval approach, the un-
derlying causes for the age and anti-TPO–related dif-
ferences in probability distributions from the reference
group in these individuals are not discussed here.How-
ever, since it is questionable whether all patients classi-
fied as having subclinical thyroid disease by the usual
definition benefit from treatment (3 ), the approach
that is based on a composite reference region appears
to be more conservative and thus may help to prevent
unnecessary treatment. A prospective study, randomly
assigning those classified as having subclinical disease
Fig. 2. Normalized, transformed TSH and FT4 values,
with conventional 1.96 SD limits (dotted lines) and
the composite limits (solid lines) as based on the
reference group.
(A), Healthy, anti-TPO–negative individuals older than 40
years and (B), the healthy, anti-TPO–positive group of
participants.
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by univariate criteria but not by the bivariate approach
to treatment or no treatment, will be required to test
this supposition.
Practical Considerations
Because of assay method differences, each laboratory
should establish its own composite reference interval,
along the guidelines given in the Appendix. Patient re-
sults must be substituted into the resulting formula for
the distance to the center of the distribution as a “thy-
roid balance index.” If the result is2.45, there should
be no need for reporting separate TSH and FT4 values,
although many physicians still may want to have these
values. For example, a TSH value of 4.2 mU/L exceeds
the 1.96 SD limit, but if FT4 is close to the average of
13.1 pmol/L the data pair remains within the compos-
ite overall 95% reference interval. For ease of use to the
physician, the calculation can be performed in the lab-
oratory instead of supplying assay results with the for-
mula. The physician will then receive a report with
TSH and FT4 results supplemented with either “Thy-
roid balance index within the reference interval” or
“Thyroid balance index outside the reference interval.”
An alternative could be to provide a diagram, prepared
by the laboratory, similar to Fig. 1A, showing only the
egg-shaped profile and grid, and plotting the reported
TSH and FT4 results to see if the data pair falls within
the reference region, and if not, what clinical category is
likely to apply. If “screening by TSH” as a first step is
common practice, the warning limits for ordering FT4
may be kept at the univariate P2.5 and P97.5 for TSH. If
these warning limits are exceeded, subsequent FT4
measurement will reveal if the same holds with regard
to the bivariate reference limit. Such a strategy limits
the number of unnecessary FT4 measurements and
does not impair diagnostic sensitivity compared to a
bivariate approach.
In conclusion, the proposed bivariate reference in-
terval for TSH and FT4 may lead to a better definition
of subclinical thyroid conditions with fewer false posi-
tives. Its implementation can be readily included in ex-
isting diagnostic strategies.
Appendix
TRANSFORMATION OF DATA
In Excel, to each tabulated TSH and FT4 value the same
offset (9 ) was added and the logarithm of the sum was
calculated. The skewness of the distribution of trans-
formed values of the healthy group was expressed as
(mean  median)/SD, i.e., Pearson’s skewness index
divided by 3 (7 ), and the value of the offset was ob-
tained by adjusting until a skewness index value of
0.001 times its original value had been reached. Fi-
nally, from each transformed value the mean was sub-
tracted and the difference was divided by the SD to
obtain values following a standard normal distribu-
tion. This was confirmed by Kolmogorov–Smirnov
testing. Symmetry was further ascertained by compar-
ing the numbers of individuals exceeding 1.96 SD
limits by the z-test for population proportions.
REMOVAL OF OUTLIERS
An outlier was defined as a value for which the proba-
bility not to be encountered at all in a sample of the
same size as the populationwas 50%,whichmeans that
the probability of finding at least 1 observation exceed-
ing this valuewas 50%or less. For a sample size of 4523,
this holds for values of P 0.00015 or3.61 SD from
the mean, according to the following formula:
P  1  0.51/4523  0.000153.
Because the3.61 interval for TSH extends beyond the
detection limit of the assay, it seemed sensible to ex-
clude all values below this limit.
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